Endocrine Technology, L.L.C. is New York based Biotechnology Company detailed at www.etbondusa.com . While responding to a patient’s request for the cure of diabetes, we develop several patents in both USA and India. We have broad portfolio of therapeutic products for major life threatening diseases. Currently we are focusing on “The Cure of Diabetes and its complications”. We have a medical division and partnership with a Clinical Research Organization Firm – Park alliance Research. We are a principal investigator for the company. We enroll patients for clinical research studies for novel diabetic drugs funded by other pharmaceutical companies.
We are principal investigator for Clinical Researxh Organization Park Research alliances, Inc (www.parkresearchalliance.com). This allows us networking opportunities with pharmaceutical companies, physicians and patients to serve clinical trial needs of large pharmaceutical companies in phase 3 and phase 4 clinical trials.
As a board certified physician in diabetes and endocrinology, we use our professional knowledge and combine with patented knowledge base to provide superior consulting services in diabetes, endocrinology and in major life threatening diseases to select patients searching for better therapeutic options for their life threatening diseases.
Through Nine Sigma. com, an open platform for innovation, we are technology expert to evaluate for beta testing of technologies developed by select universities.
Through Nine sigma.com, an open innovation platform for technology, we are responding to the needs of pharma companies to help them develop innovative products through our patented technology.
Through Nine sigma.com platform for open innovation, we are offering our technology for licensing and further development in major twenty five life threatening diseases.